反応式
[N:1]([C:4]1[CH:9]=[CH:8][C:7]([N:10]2[CH2:15][CH2:14][N:13]([CH3:16])[CH2:12][CH2:11]2)=[CH:6][CH:5]=1)=[C:2]=[S:3].[N:17]#[C:18][NH2:19].CC(C)([O-])C.[K+].Br[CH2:27][C:28]([C:30]1[CH:35]=[CH:34][C:33]([N:36]2[CH2:40][CH2:39][CH2:38][CH2:37]2)=[CH:32][CH:31]=1)=[O:29]>C(#N)C.C(O)(C)(C)C>[NH2:17][C:18]1[N:19]=[C:2]([NH:1][C:4]2[CH:5]=[CH:6][C:7]([N:10]3[CH2:11][CH2:12][N:13]([CH3:16])[CH2:14][CH2:15]3)=[CH:8][CH:9]=2)[S:3][C:27]=1[C:28]([C:30]1[CH:35]=[CH:34][C:33]([N:36]2[CH2:40][CH2:39][CH2:38][CH2:37]2)=[CH:32][CH:31]=1)=[O:29]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
tert-Butanol (4 mL) and then 1-(4-isothiocyanatophenyl)-4-methyl piperazine (of Example 1; 219 mg, 1 mmol) were added to a solution of cyanamide (44 mg, 1.05 mmol) in acetonitrile (5 mL). Potassium t-butoxide (1 M in tert-butanol; 1 mL, 1 mmol) was added and the solution was stirred for 30 min. 2-Bromo-1-[4-(1-pyrrolidinyl)phenyl]ethanone (257 mg, 1 mmol) (Lancaster) was added, and the solution was stirred at room temperature for 2 days. The yellow-brown solid was filtered off and washed with cold acetonitrile, water and then cold acetonitrile (weight of solid: 271 mg). A portion of this crude product (50 mg) was purified by chromatography (10% methanol/dichloromethane) to give [4-amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl][4-(1-pyrrolidinyl) phenyl]methanone (18.5 mg).
後処理
- stirringthe solution was stirred at room temperature for 2 days
- filtrationThe yellow-brown solid was filtered off
- washwashed with cold acetonitrile, water
- customA portion of this crude product (50 mg) was purified by chromatography (10% methanol/dichloromethane)
出典と根拠
- ORDレコード
- ord-b17a0c7b6d284d0a959d2f696bb214cf
- 出典データセット
- uspto-grants-2006_08
- 特許番号
- US07094896B2
関連ノート
読み込み中…